$62.13
-0.56[-0.89%]
At close: Jun 14
$62.13
0[0.00%]
After Hours: 5:53PM EDT
Incyte
(NASDAQ:INCY)Incyte (NASDAQ:INCY) Stock, Analyst Ratings, Price Targets, Predictions
Incyte Corp has a consensus price target of $67.28, established from looking at the 87 latest analyst ratings. The last 3 analyst ratings were released from Deutsche Bank, TD Cowen, and Truist Securities on May 23, 2024, May 1, 2024, and May 1, 2024. With an average price target of $72.67 between Deutsche Bank, TD Cowen, and Truist Securities, there's an implied 16.96% upside for Incyte Corp from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Deutsche Bank
TD Cowen
Truist Securities
BMO Capital
Oppenheimer
1calculated from analyst ratings
Analyst Ratings for Incyte
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/23/2024 | Buy Now | -11.48% | Deutsche Bank | James Shin | → $55 | Initiates | → Hold | Get Alert |
| 05/01/2024 | Buy Now | 28.76% | TD Cowen | Marc Frahm | $88 → $80 | Maintains | Buy | Get Alert |
| 05/01/2024 | Buy Now | 33.59% | Truist Securities | Srikripa Devarakonda | $84 → $83 | Reiterates | Buy → Buy | Get Alert |
| 05/01/2024 | Buy Now | -16.3% | BMO Capital | Evan Seigerman | $56 → $52 | Maintains | Market Perform | Get Alert |
| 04/24/2024 | Buy Now | 35.2% | Oppenheimer | Jay Olson | $92 → $84 | Maintains | Outperform | Get Alert |
| 04/23/2024 | Buy Now | — | Cantor Fitzgerald | Eric Schmidt | — | Initiates | → Neutral | Get Alert |
| 03/25/2024 | Buy Now | 4.62% | RBC Capital | Brian Abrahams | → $65 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 03/13/2024 | Buy Now | 7.84% | B of A Securities | Tazeen Ahmad | $69 → $67 | Maintains | Neutral | Get Alert |
| 03/12/2024 | Buy Now | 9.45% | Stifel | Stephen Willey | → $68 | Reiterates | Hold → Hold | Get Alert |
| 03/12/2024 | Buy Now | 4.62% | RBC Capital | Brian Abrahams | → $65 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 02/23/2024 | Buy Now | 30.37% | Jefferies | Kelly Shi | → $81 | Initiates | → Buy | Get Alert |
| 02/14/2024 | Buy Now | — | JMP Securities | Reni Benjamin | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 02/14/2024 | Buy Now | 3.01% | BMO Capital | Evan Seigerman | $58 → $64 | Maintains | Market Perform | Get Alert |
| 02/14/2024 | Buy Now | 30.37% | Citigroup | David Lebowitz | $82 → $81 | Maintains | Buy | Get Alert |
| 02/14/2024 | Buy Now | 4.62% | RBC Capital | Brian Abrahams | $63 → $65 | Maintains | Sector Perform | Get Alert |
| 02/14/2024 | Buy Now | 9.45% | Stifel | Stephen Willey | $67 → $68 | Maintains | Hold | Get Alert |
| 02/14/2024 | Buy Now | 35.2% | Truist Securities | Srikripa Devarakonda | $91 → $84 | Maintains | Buy | Get Alert |
| 12/14/2023 | Buy Now | 23.93% | Mizuho | Mara Goldstein | $82 → $77 | Maintains | Neutral | Get Alert |
| 12/13/2023 | Buy Now | 49.69% | JMP Securities | Reni Benjamin | → $93 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 12/13/2023 | Buy Now | 25.54% | Leerink Partners | Andrew Berens | → $78 | Upgrade | Market Perform → Outperform | Get Alert |
| 12/04/2023 | Buy Now | — | Guggenheim | Michael Schmidt | — | Upgrade | Neutral → Buy | Get Alert |
| 11/29/2023 | Buy Now | 46.47% | Truist Securities | Srikripa Devarakonda | → $91 | Reiterates | Buy → Buy | Get Alert |
| 11/22/2023 | Buy Now | 4.62% | Goldman Sachs | Salveen Richter | $98 → $65 | Maintains | Neutral | Get Alert |
| 11/21/2023 | Buy Now | 4.62% | Goldman Sachs | Salveen Richter | → $65 | Downgrade | Buy → Neutral | Get Alert |
| 11/02/2023 | Buy Now | 57.73% | Goldman Sachs | Salveen Richter | $114 → $98 | Maintains | Buy | Get Alert |
| 11/01/2023 | Buy Now | 1.4% | RBC Capital | Brian Abrahams | $74 → $63 | Maintains | Sector Perform | Get Alert |
| 11/01/2023 | Buy Now | 3.01% | Morgan Stanley | Vikram Purohit | $74 → $64 | Maintains | Equal-Weight | Get Alert |
| 09/21/2023 | Buy Now | 46.47% | Truist Securities | Srikripa Devarakonda | → $91 | Reiterates | Buy → Buy | Get Alert |
| 08/02/2023 | Buy Now | 17.5% | RBC Capital | Brian Abrahams | $70 → $73 | Maintains | Sector Perform | Get Alert |
| 08/02/2023 | Buy Now | 22.32% | Stifel | Stephen Willey | $73 → $76 | Maintains | Hold | Get Alert |
FAQ
What is the target price for Incyte (INCY) stock?
The latest price target for Incyte (NASDAQ:INCY) was reported by Deutsche Bank on May 23, 2024. The analyst firm set a price target for $55.00 expecting INCY to fall to within 12 months (a possible -11.48% downside). 38 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Incyte (INCY)?
The latest analyst rating for Incyte (NASDAQ:INCY) was provided by Deutsche Bank, and Incyte initiated their hold rating.
When was the last upgrade for Incyte (INCY)?
The last upgrade for Incyte Corp happened on December 13, 2023 when Leerink Partners raised their price target to $78. Leerink Partners previously had a market perform for Incyte Corp.
When was the last downgrade for Incyte (INCY)?
The last downgrade for Incyte Corp happened on February 14, 2024 when JMP Securities changed their price target from N/A to N/A for Incyte Corp.
When is the next analyst rating going to be posted or updated for Incyte (INCY)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Incyte, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Incyte was filed on May 23, 2024 so you should expect the next rating to be made available sometime around May 23, 2025.
Is the Analyst Rating Incyte (INCY) correct?
While ratings are subjective and will change, the latest Incyte (INCY) rating was a initiated with a price target of $0.00 to $55.00. The current price Incyte (INCY) is trading at is $62.13, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.